Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart - PubMed (original) (raw)
. 2004 Jul;18(10):1153-5.
doi: 10.1096/fj.03-1308fje. Epub 2004 May 20.
Affiliations
- PMID: 15155562
- DOI: 10.1096/fj.03-1308fje
Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart
Ken Suzuki et al. FASEB J. 2004 Jul.
Abstract
Survival and proliferation of skeletal myoblasts within the cardiac environment are crucial to the therapeutic efficacy of myoblast transplantation to the heart. We have analyzed the early dynamics of myoblasts implanted into the myocardium and investigated the mechanisms underlying graft attrition. At 10 min after implantation of [14C]thymidine-labeled male myoblasts into female mice hearts, 14C measurement showed that 39.2 +/- 3.0% of the grafted cells survived, and this steadily decreased to 16.0 +/- 1.7% by 24 h and to 7.4 +/- 0.9% by 72 h. PCR of male-specific Smcy gene calculated that the total (surviving plus proliferated) number of donor-derived cells was 18.3 +/- 1.6 and 23.3 +/- 1.3% at 24 and 72 h, respectively, indicating that proliferation of the surviving cells began after 24 h. Acute inflammation became prominent by 24 h and was reduced by 72 h as indicated by myeloperoxidase activity and histological findings. Multiplex RT-PCR revealed corresponding changes in IL-1beta, TGF-beta, IL-6, and TNF-alpha expression. Treatment with CuZn-superoxide dismutase attenuated the initial rapid death and resulted in enhanced cell numbers afterward, giving a twofold increased total number at 72 h compared with the nontreatment. This effect was associated with reduced inflammatory response, suggesting a causative role for superoxide in the initial rapid graft death and subsequent inflammation. These data describe the early dynamics of myoblasts implanted into the myocardium and suggest that initial oxidative stress and following inflammatory response may be important mechanisms contributing to acute graft attrition, both of which could be potential therapeutic targets to improve the efficiency of cell transplantation to the heart.
Similar articles
- Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart.
Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH. Suzuki K, et al. Circulation. 2004 Sep 14;110(11 Suppl 1):II219-24. doi: 10.1161/01.CIR.0000138388.55416.06. Circulation. 2004. PMID: 15364866 - Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Guérette B, Skuk D, Célestin F, Huard C, Tardif F, Asselin I, Roy B, Goulet M, Roy R, Entman M, Tremblay JP. Guérette B, et al. J Immunol. 1997 Sep 1;159(5):2522-31. J Immunol. 1997. PMID: 9278346 - Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium.
Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, Yacoub MH. Murtuza B, et al. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4216-21. doi: 10.1073/pnas.0306205101. Epub 2004 Mar 12. Proc Natl Acad Sci U S A. 2004. PMID: 15020774 Free PMC article. - Skeletal myoblasts for cardiac repair.
Durrani S, Konoplyannikov M, Ashraf M, Haider KH. Durrani S, et al. Regen Med. 2010 Nov;5(6):919-32. doi: 10.2217/rme.10.65. Regen Med. 2010. PMID: 21082891 Free PMC article. Review. - Skeletal myoblasts as a therapeutic agent.
Menasché P. Menasché P. Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):7-17. doi: 10.1016/j.pcad.2007.02.002. Prog Cardiovasc Dis. 2007. PMID: 17631434 Review.
Cited by
- Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.
Jadczyk T, Faulkner A, Madeddu P. Jadczyk T, et al. Br J Pharmacol. 2013 May;169(2):247-68. doi: 10.1111/j.1476-5381.2012.01965.x. Br J Pharmacol. 2013. PMID: 22712727 Free PMC article. Review. - Mechanical loading of stem cells for improvement of transplantation outcome in a model of acute myocardial infarction: the role of loading history.
Cassino TR, Drowley L, Okada M, Beckman SA, Keller B, Tobita K, Leduc PR, Huard J. Cassino TR, et al. Tissue Eng Part A. 2012 Jun;18(11-12):1101-8. doi: 10.1089/ten.TEA.2011.0285. Epub 2012 Mar 7. Tissue Eng Part A. 2012. PMID: 22280442 Free PMC article. - Clinical trials of cardiac repair with adult bone marrow- derived cells.
Jeevanantham V, Afzal MR, Zuba-Surma EK, Dawn B. Jeevanantham V, et al. Methods Mol Biol. 2013;1036:179-205. doi: 10.1007/978-1-62703-511-8_15. Methods Mol Biol. 2013. PMID: 23807796 Free PMC article. - Stem cells and cardiac repair: a critical analysis.
Dinsmore JH, Dib N. Dinsmore JH, et al. J Cardiovasc Transl Res. 2008 Mar;1(1):41-54. doi: 10.1007/s12265-007-9008-7. Epub 2008 Jan 31. J Cardiovasc Transl Res. 2008. PMID: 20559957 Review. - Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts.
Don CW, Murry CE. Don CW, et al. J Cell Mol Med. 2013 Nov;17(11):1355-62. doi: 10.1111/jcmm.12147. Epub 2013 Oct 9. J Cell Mol Med. 2013. PMID: 24118766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials